New GLP-1 Concern; FDA Sued by Health Groups; Over 750 Dead in Ebola Outbreak
(MedPage Today) -- Note that some links may require registration or subscription. A preprint study flagged signals of frailty in seniors taking the GLP-1 drug tirzepatide (Zepbound) for weight loss…
Read the full article3d agoen
Comments
Sign in to join the conversation.
No comments yet. Be the first.